TCM Intrinsic Value
TCM (TCMLMTD) median intrinsic value is ₹36.25 from 2 valuation models (range ₹28–₹36), vs current price ₹49.09 — -26.2% downside (Trading Above Calculated Value), margin of safety -35.4%. For current market price and key ratios, visit TCMLMTD stock price BSE.
TCMLMTD Valuation Methods Summary — DCF, Graham Number & P/E
TCM intrinsic value across 2 models vs current price ₹49.09 — upside/downside and value range per method. Also explore TCMLMTD price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹36.25 | ₹32.62 - ₹39.88 | -26.2% | Book Value/Share: ₹36.25, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹28.00 | ₹25.20 - ₹30.80 | -43.0% | Revenue/Share: ₹35.00, P/S: 0.8x |
TCMLMTD Intrinsic Value vs Market Price — All Valuation Models
TCM fair value range ₹28–₹36 vs current market price ₹49.09 across 2 valuation models. Browse TCMLMTD income statement for revenue, profit, balance sheet and cash flow data.
TCMLMTD Intrinsic Value Analysis — Undervalued or Overvalued?
TCM median intrinsic value ₹36.25, current price ₹49.09 — Trading Above Calculated Value by 26.2%, margin of safety -35.4%.
What is the intrinsic value of TCMLMTD?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of TCM (TCMLMTD) is ₹36.25 (median value). With the current market price of ₹49.09, this represents a -26.2% variance from our estimated fair value.
The valuation range spans from ₹28.00 to ₹36.25, indicating ₹28.00 - ₹36.25.
Is TCMLMTD undervalued or overvalued?
Based on our multi-method analysis, TCM (TCMLMTD) appears to be trading above calculated value by approximately 26.2%.
TCMLMTD Financial Health — Key Ratios vs Industry Benchmarks
TCM financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -13.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -14.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.37x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
TCMLMTD Cash Flow Quality — Operating & Free Cash Flow
TCM operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-11 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |